Losartan and azelastine either alone or in combination as modulators for endothelial dysfunction and platelets activation in diabetic hyperlipidemic rats.
J Pharm Pharmacol
; 72(12): 1812-1821, 2020 Dec.
Article
in En
| MEDLINE
| ID: mdl-32880967
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phthalazines
/
Blood Platelets
/
Platelet Activation
/
Losartan
/
Histamine H1 Antagonists, Non-Sedating
/
Endothelial Cells
/
Angiotensin II Type 1 Receptor Blockers
/
Diabetes Mellitus, Experimental
/
Hyperlipidemias
/
Hypolipidemic Agents
Type of study:
Etiology_studies
/
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
J Pharm Pharmacol
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: